The Pharma Legal Handbook: Portugal

Portugal is a European Union member state with a pharmaceutical regulatory framework administered by INFARMED, the National Authority of Medicines and Health Products. Portugal's pricing and reimbursement system operates under the National Health Service (SNS) framework, with reimbursement decisions made by INFARMED following a health technology assessment process.

Portugal has been subject to significant pharmaceutical pricing reforms as part of broader healthcare spending controls, and the net prices achieved after mandatory rebates and discounts require careful modelling for commercial planning. Portugal is also a significant source of parallel exports within the EU, which has implications for brand holders.

The Pharma Legal Handbook: Portugal provides comprehensive guidance on pharmaceutical regulation in Portugal, covering INFARMED product authorisation, SNS pricing and reimbursement pathways, clinical trial requirements, pharmacovigilance obligations, manufacturing standards, marketing rules, parallel imports, and intellectual property protection.